Company

Provexis plc

Headquarters: Reading, United Kingdom

Employees: 2

CEO: Mr. Ian Ford BA (Hons) ACA

LSE: PXS -12.37%

Market Cap

£13.6 Million

GBP as of July 1, 2024

US$17.2 Million

Market Cap History

Provexis plc market capitalization over time

Evolution of Provexis plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Provexis plc

Detailed Description

Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Provexis plc has the following listings and related stock indices.


Stock: LSE: PXS wb_incandescent

Details

Headquarters:

2 Blagrave Street

Reading, RG1 1AZ

United Kingdom

Phone: 44 7490 391 888